HealthTree COVID-19 Myeloma Patient Study and Antibody Test
Myeloma Crowd and HealthTree have opened a COVID-19 Myeloma Patient Study. It is a series of questions that have been created by the Myeloma Crowd Multiple Myeloma Research Review Board. These myeloma experts and the Myeloma Crowd want to know how COVID-19 is affecting myeloma patients.

The PMMNG has supported the University of Pennsylvania Abramson Cancer Center for some time in their development of a survey on the topic of financial toxicity for myeloma patients. The survey is ready now, and we invite you to participate in this study to help our research community better understand the impact of our treatments on the non-medical side of our lives. The study is being led by Ch




